BACKGROUND: Despite the numerous advances in medical treatment, it is estimated that a significant percentage of patients with Crohn's disease (CD) requires bowel resection at least once....
1 University of São Paulo School of Medicine, Department of Medicine, Ribeirão Preto, Brazil;
2 Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, ...
INTRODUCTION: Infliximab, an antibody against tumor necrosis factor (TNF) alpha with well-established efficacy and proven safety, is currently widely used in Crohn's disease treatmen...